SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-009246
Filing Date
2017-05-08
Accepted
2017-05-08 08:30:26
Documents
2
Period of Report
2017-05-02
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ANNUAL MEETING fate-8k_20170502.htm 8-K 50213
2 EX-10.1 fate-ex101_6.htm EX-10.1 510362
  Complete submission text file 0001564590-17-009246.txt   561748
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36076 | Film No.: 17820669
SIC: 2836 Biological Products, (No Diagnostic Substances)